tradingkey.logo

Sandoz Files Antitrust Litigation Against Amgen In The US

ReutersApr 14, 2025 5:02 AM

-

  • SANDOZ FILES ANTITRUST LITIGATION AGAINST AMGEN REGARDING PATIENT ACCESS TO ETANERCEPT BIOSIMILAR IN THE US

  • SANDOZ GROUP AG - FILES ANTITRUST LAWSUIT AGAINST AMGEN IN US

  • SANDOZ GROUP AG - ALLEGES AMGEN BLOCKED BIOSIMILAR COMPETITION

  • SANDOZ GROUP AG - SEEKS INJUNCTION TO PREVENT AMGEN FROM BLOCKING BIOSIMILAR COMPETITION

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI